Understanding 5CLADBA: An Overview For Responsible Research - Versionsgeschichte

MariaKimbrell2 am 18. Mai 2026 um 06:59 Uhr

2026-05-18T06:59:54Z

← Nächstältere Version		Version vom 18. Mai 2026, 07:59 Uhr
Zeile 1:		Zeile 1:
	~~4. Drugs <br>In general, the locomotor depressant~~ and ~~discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH~~-~~210~~ (~~Gatch et al., 2016~~), ~~and 5F~~-~~AMB produced sustained vocalization~~ and ~~convulsions in rats~~ (~~Gatch~~ et al., ~~2018~~). ~~All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative~~ stimulus effects ~~of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons~~ were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in ~~mice was tested~~ to ~~screen for locomotor depressant effects and to identify behaviorally~~-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg ~~AMB~~-~~FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10~~ min~~, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ 5CLADBA] highest dose tested (0.5 mg/kg~~).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA~~, was found to activate midbrain dopamine neurons, but not serotonin neurons~~ (~~Asaoka et al.~~, ~~2016). As previously mentioned, all of the compounds tested in the present study (MDMB~~-PINACA, MDMB-~~CHMICA~~, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA~~) act~~ as ~~agonists at CB1 receptors (Banister et al.~~, ~~2015, 2016; Gamage et al., 2018~~)~~, which suggests these compounds will produce Δ9-THC~~-like effects~~, including~~ abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic<br><br>In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day<br><br>~~Fig. 2.~~ <br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender ~~5CLADBA~~ and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>~~Data concerning the combined effects of SCRAs~~ and ~~other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult~~ . The ~~threshold SCRA~~ concentration ~~for fatal overdose can be estimated ng/mL level~~ (0.~~37–4~~.~~1 ng~~/~~mL according to the reported cases~~) ~~in cases in which 1~~.~~5–2~~.~~5 g/L~~ of ~~ethanol~~ is ~~present in~~ the ~~blood~~. ~~The victims were brothers~~ who ~~were both found deceased~~ after ~~consuming 4F~~-~~MDMB~~-~~BINACA and ethanol~~. ~~These confusing shorter names were~~ not ~~scientifically adopted but were~~ used by ~~websites selling~~ the ~~drugs to~~ the ~~public~~. ~~Monitoring metabolism~~ of ~~synthetic cannabinoid 4F~~-~~MDMB-BINACA via high-resolution mass spectrometry assessed~~ in ~~cultured hepatoma cell line~~, ~~fungus~~, ~~liver microsomes~~ and ~~confirmed using~~ urine samples. ~~This article does not contain any studies with human participants or animals performed by any of the author~~<br><br>Despite ~~all negative results~~ in the ~~point~~-~~of-care test for recreational drugs~~, the ~~liquid chromatography-quadrupole time-of-flight mass spectrometry~~ (LC-~~QTOF-MS~~) ~~analysis showed~~ that the ~~liquid~~ of ~~the e-cigarette contained~~ ADB-BUTINACA, ~~a synthetic cannabinoi~~		These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender 4F ADB and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>Victim B also brought "something resembling a drug" (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2, in vitro half-life (t1/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours<br><br><br>Demographic and clinical features are recorded and blood and/or urine samples analysed using high-resolution accurate mass liquid chromatography-mass spectrometry. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Second, we could not [https://cannabinoidsrc4f-adb.com/ 4F ADB] retrieve further detailed information about the e-cigarette that was used by the patient such as the label or the region of origin. Whether a recreational drug can be administered via vaping, depends on whether the drug becomes volatile under the evaporation temperature of the e-cigarette. Of these samples, 22 contained one or more SCRAs, THC was only detected in 11 samples, only one contained cannabidiol and 6 contained a mixture of THC and cannabidiol. There is difficulty in finding the right information about the NPS, defining their potency and confirmation of their existence in e-liquids or urine samples.<br>Data availabili<br><br>Despite the relatively high % peak area ratio and detection in 16/20 urine samples, ester hydrolysis followed by monohydroxylation at the tert-leucine moiety (m/z 366, B8) metabolite was not reported among the 17 urine samples from the forensic psychiatric ward and prison in Haschimi et al.’s study<br><br><br>As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali

JonnaNesbit am 17. Mai 2026 um 07:09 Uhr

2026-05-17T07:09:04Z

← Nächstältere Version		Version vom 17. Mai 2026, 08:09 Uhr
Zeile 1:		Zeile 1:
	~~Moreover~~, ~~a study conducted~~ in ~~the United Kingdom investigated components of e~~-~~liquids in 112 samples originating from prisoners~~, ~~teenagers~~ and ~~test purchases of commercially available e~~-~~cigarettes taken between 2014~~ and ~~2021~~ . ~~This is~~ the ~~first case report that describes~~ the ~~toxicological symptoms~~ of ~~vaping ADB~~-~~BUTINACA~~. ~~Results~~ of the ~~DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis~~, ~~tricyclic antidepressants) were available within 30 minutes~~ and were ~~all negative~~. ~~We report~~ a ~~case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping~~. ~~There are several pitfalls~~ in ~~the detection~~ of ~~SCRA in samples taken from~~ the ~~patien~~<br><br>~~<br>In summary~~, ~~JWH~~-~~210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency~~, and ~~reliability~~. ~~This commitment~~ to [https://cannabinoidsrc4f-adb.com/ ~~adb butinaca~~] ~~quality makes it a trusted option for professionals who require dependable compounds for their work~~. From sourcing raw materials to final packaging, every stage of the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards.<br>~~Key Features and Specifications to Evaluate~~ <br>~~In case~~ of ~~cannabis or Δ9~~-~~tetrahydrocannabinol, there are many adb butinaca previous studies regarding with their dependence potential~~ and ~~neurotoxicity~~ (~~Cororan,~~ et al., ~~1974; Harris~~, ~~et al.~~, ~~1974; Leite and Culini~~, ~~1974; Hutcheson~~, et al., ~~1998~~). ~~After administering test substances once every other day for 10 days~~, ~~brain samples~~ of ~~mice were collected, especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day, and~~ the ~~first trial was performed 2 h after~~ the ~~last administration.<br>How to Choose Powder JWH~~-~~210 <br>This dual~~-~~use nature underscores the importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs~~, ~~public health researchers~~, and ~~customs officials use authentic samples like JWH~~-~~210 to distinguish between legal and illegal compounds in seized materials~~. ~~For those seeking a dependable compound for analytical purposes~~, ~~JWH-210 Chemical Powder provides a trusted and effective solution~~. ~~With its carefully controlled production process~~, ~~stable composition~~, ~~and secure packaging~~, ~~it remains a valuable resource for laboratory-based research~~.~~<br>Is JWH~~-~~210 Legal? <br>To evaluate whether~~ the ~~changes of coordinative functions by CNS damages were due to test substances~~, ~~rota-rod test~~ was ~~performed using Rota~~-~~rod apparatus (Daejong, Seoul, Korea). The test apparatus for~~ the ~~locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051, Benwick Electronics, Benwick, UK) when experimental animals moved~~ in the ~~chamber.~~ In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day<br><br><br>In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and ~~water-maze test for learning~~/~~memory evaluation. Known for its stability and consistent composition~~, ~~this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies~~. ~~In this study, histopathological evaluation~~ was performed ~~to confirm~~ the ~~possibility~~ of ~~neurotoxicity~~ of the ~~tested substances by hematoxylin and eosin staining method from collected brain samples~~. In the ~~present study, we evaluated~~ the ~~neurotoxicity of two synthetic cannabinoids (JWH~~-~~081~~ and ~~JWH-210) through observation of various behavioral changes~~ and ~~analysis of histopathological changes using experimental mice with various doses (0~~.1, ~~1, 5 mg/kg). Selecting powder JWH~~-~~210 demands careful evaluation~~ of ~~purity~~, ~~legality~~, and ~~supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity~~, and ~~vendor complianc<br><br><br>A 30-min period~~, ~~beginning when maximal depression of locomotor activity first appeared as a function of dose~~, ~~was used for analysis of dose-response data~~ and ~~calculation~~ of ~~ED50 values~~. ~~During test sessions, both levers were active, such~~ that ~~ten consecutive responses on either lever led~~ to ~~adb butinaca reinforcement. The substitution tests occurred only if the rats had achieved 85% injection-appropriate responding on the two prior training sessions~~.<br>~~The locomotor activity assay was used to identify approximate time courses~~ and ~~dose ranges of psychoactive effects~~, which ~~is useful~~ for ~~identifying parameters for drug discrimination experiments and are also predictive of~~ the ~~time course~~ of the ~~psychoactive effects in human users~~. The ~~purpose of~~ the ~~present study was~~ to ~~assess~~ the ~~abuse liability~~ of 5F-MDMB-~~PINACA, MDMB~~-~~CHIMICA~~, ~~MDMB-FUBINACA, ADB-FUBINACA~~, and ~~AMB-FUBINACA~~. ~~Since there is currently no robust measure~~ of the ~~reinforcing/rewarding effects~~ of ~~cannabinoids~~, ~~drug discrimination is currently~~ the ~~best model for assessing abuse liability~~ of ~~cannabinoids. The findings produce an apparent paradox, since CPP and self~~-~~administration predict with high reliability~~ the ~~likelihood that a compound will be abused by humans, and cannabinoids are well~~-~~known to produce active drug~~-~~seeking in human~~		4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ 5CLADBA] highest dose tested (0.5 mg/kg).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic<br><br>In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day<br><br>Fig. 2. <br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender 5CLADBA and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level (0.37–4.1 ng/mL according to the reported cases) in cases in which 1.5–2.5 g/L of ethanol is present in the blood. The victims were brothers who were both found deceased after consuming 4F-MDMB-BINACA and ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author<br><br>Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoi

NoeCanela7: Die Seite wurde neu angelegt: „Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioi…“

2026-05-16T07:01:43Z

Die Seite wurde neu angelegt: „Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioi…“

Neue Seite

Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes and were all negative. We report a case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping. There are several pitfalls in the detection of SCRA in samples taken from the patien In summary, JWH-210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency, and reliability. This commitment to [https://cannabinoidsrc4f-adb.com/ adb butinaca] quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging, every stage of the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards. Key Features and Specifications to Evaluate In case of cannabis or Δ9-tetrahydrocannabinol, there are many adb butinaca previous studies regarding with their dependence potential and neurotoxicity (Cororan, et al., 1974; Harris, et al., 1974; Leite and Culini, 1974; Hutcheson, et al., 1998). After administering test substances once every other day for 10 days, brain samples of mice were collected, especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day, and the first trial was performed 2 h after the last administration. How to Choose Powder JWH-210 This dual-use nature underscores the importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers, and customs officials use authentic samples like JWH-210 to distinguish between legal and illegal compounds in seized materials. For those seeking a dependable compound for analytical purposes, JWH-210 Chemical Powder provides a trusted and effective solution. With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory-based research. Is JWH-210 Legal? To evaluate whether the changes of coordinative functions by CNS damages were due to test substances, rota-rod test was performed using Rota-rod apparatus (Daejong, Seoul, Korea). The test apparatus for the locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051, Benwick Electronics, Benwick, UK) when experimental animals moved in the chamber. In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and calculation of ED50 values. During test sessions, both levers were active, such that ten consecutive responses on either lever led to adb butinaca reinforcement. The substitution tests occurred only if the rats had achieved 85% injection-appropriate responding on the two prior training sessions. The locomotor activity assay was used to identify approximate time courses and dose ranges of psychoactive effects, which is useful for identifying parameters for drug discrimination experiments and are also predictive of the time course of the psychoactive effects in human users. The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA. Since there is currently no robust measure of the reinforcing/rewarding effects of cannabinoids, drug discrimination is currently the best model for assessing abuse liability of cannabinoids. The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human